Sign In
2 Mar 2011 08:14
2 March 2011
Toumaz Limited
£1.8m raised from strategic and institutional investors
Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in low cost, ultra low power wireless communications and broadcast technology, announces that Quanta Computer Inc. (RIC: 2382.tw, 'Quanta') has increased its investment in the Group, representing a stake of 2.22% in the enlarged Group and amounted to £1.2m.
Separately, Toumaz has also issued 7.25m shares to an institutional shareholder at 8.83p per share, representing a stake of 1.15% in the enlarged Group, and raising £0.6m.
In total, this has raised £1.8m for the Group. Following admission, there will be 629,437,868 shares in issue. Application will be made for the shares to be admitted to trading on AIM on 4 March 2011.
Quanta and Toumaz will collaborate to develop Toumaz's market leading, low power wireless healthcare and wellness technology, for use by individuals outside of the hospital environment.
Toumaz also has separate strategic relationships in place for the commercialisation of Sensium based products for continuous monitoring in hospitals and on 10 February 2011, Dr. Patrick Soon-Shiong invested £1.3m to develop the Sensium platform for use in sport.
Professor Chris Toumazou, CEO of Toumaz, commented:
"The opportunity that collaborating with the world's largest laptop ODM will bring is very exciting and will be a key step towards becoming the leading technology provider for wireless healthcare.
"Quanta's additional investment is a strong endorsement of our strategy of diversifying the Sensium platform beyond the hospital environment."
Barry Lam, Chairman and CEO of Quanta, said:
"We are impressed by Toumaz's technology and believe that wireless monitoring in the home will be a key area for health in the future. We look forward to working closely with Toumaz on innovative products for this growing market."
Enquiries:
Toumaz Holdings Limited | 020 7355 0036 |
Chris Toumazou, Chief Executive Officer |
|
Patrick Stephansen, Chief Financial Officer |
|
|
|
FinnCap | 020 7600 1658 |
Charles Cunningham (Corporate Finance) |
|
Brian Patient (Corporate Broking) |
|
|
|
College Hill | 020 7457 2020 |
Adrian Duffield/Rozi Morris |
About Toumaz (www.toumaz.com)
Toumaz is pioneering low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.
Targeting the Healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in real-time wireless monitoring of the body's vital signs. Sensium has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.
Toumaz also uses its ultra low power expertise to design devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to leaders in the digital radio market, such as PURE.
Toumaz is an AIM listed company (AIM: TMZ) with development centres in Oxford, UK and Taipei City, Taiwan.
Follow the stocks
